Free Trial

Danaher (DHR) Stock Price, News & Analysis

Danaher logo
$199.45 -1.65 (-0.82%)
As of 11:00 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Danaher Stock (NYSE:DHR)

Key Stats

Today's Range
$199.35
$202.39
50-Day Range
$184.79
$204.85
52-Week Range
$171.00
$281.70
Volume
584,597 shs
Average Volume
3.50 million shs
Market Capitalization
$142.74 billion
P/E Ratio
38.76
Dividend Yield
0.64%
Price Target
$248.61
Consensus Rating
Moderate Buy

Company Overview

Danaher Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
97th Percentile Overall Score

DHR MarketRank™: 

Danaher scored higher than 97% of companies evaluated by MarketBeat, and ranked 51st out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Danaher has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 16 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Danaher has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Danaher's stock forecast and price target.
  • Earnings Growth

    Earnings for Danaher are expected to grow by 12.32% in the coming year, from $7.63 to $8.57 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Danaher is 38.75, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.07.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Danaher is 38.75, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.23.

  • Price to Earnings Growth Ratio

    Danaher has a PEG Ratio of 2.77. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Danaher has a P/B Ratio of 2.91. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Danaher's valuation and earnings.
  • Percentage of Shares Shorted

    1.19% of the float of Danaher has been sold short.
  • Short Interest Ratio / Days to Cover

    Danaher has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Danaher has recently increased by 4.17%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Danaher has a dividend yield of 0.65%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Danaher has only been increasing its dividend for 2 years.

  • Dividend Coverage

    The dividend payout ratio of Danaher is 24.85%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Danaher will have a dividend payout ratio of 14.94% next year. This indicates that Danaher will be able to sustain or increase its dividend.

  • Read more about Danaher's dividend.
  • Percentage of Shares Shorted

    1.19% of the float of Danaher has been sold short.
  • Short Interest Ratio / Days to Cover

    Danaher has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Danaher has recently increased by 4.17%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Danaher has a news sentiment score of 1.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 52 news articles for Danaher this week, compared to 29 articles on an average week.
  • Search Interest

    Only 18 people have searched for DHR on MarketBeat in the last 30 days. This is a decrease of -5% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added Danaher to their MarketBeat watchlist in the last 30 days. This is an increase of 17% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Danaher insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $249,054,390.00 in company stock.

  • Percentage Held by Insiders

    11.20% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    79.05% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Danaher's insider trading history.
Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

DHR Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Is Danaher's M&A Premium Already Priced In?
Danaher Welcomes New CTO, Shares Strengthen
See More Headlines

DHR Stock Analysis - Frequently Asked Questions

Danaher's stock was trading at $229.55 at the beginning of the year. Since then, DHR shares have decreased by 12.9% and is now trading at $199.96.
View the best growth stocks for 2025 here
.

Danaher Corporation (NYSE:DHR) issued its quarterly earnings data on Tuesday, April, 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The conglomerate had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 15.81% and a trailing twelve-month return on equity of 10.80%.
Read the conference call transcript
.

Danaher subsidiaries include these companies: Aldevron, Precision NanoSystems, Aquatic Informatics, Cytiva, GE Biopharma, Integrated DNA Technologies, IDBS Group, and more.

Danaher's top institutional shareholders include Park National Corp OH (0.01%), Neville Rodie & Shaw Inc. (0.01%), Legacy Wealth Management LLC MS and Harbor Investment Advisory LLC. Insiders that own company stock include Steven M Rales, Alan G Spoon, Rainer Blair, Joakim Weidemanis, Linda Filler, Daniel Raskas, Matthew Mcgrew, Brian W Ellis, Teri List, Christopher Paul Riley, Walter G Lohr, Raymond C Stevens, Jennifer Honeycutt, Jose-Carlos Gutierrez-Ramos and Georgeann Couchara.
View institutional ownership trends
.

Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Danaher investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), UnitedHealth Group (UNH), BlackRock (BLK), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD).

Company Calendar

Record date for 4/25 Dividend
3/28/2025
Ex-Dividend for 4/25 Dividend
3/28/2025
Last Earnings
4/22/2025
Dividend Payable
4/25/2025
Record date for 7/25 Dividend
6/27/2025
Today
7/02/2025
Next Earnings (Estimated)
7/22/2025
Dividend Payable
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Industrial Conglomerates
Current Symbol
NYSE:DHR
Employees
63,000
Year Founded
1984

Price Target and Rating

Average Stock Price Target
$248.61
High Stock Price Target
$315.00
Low Stock Price Target
$210.00
Potential Upside/Downside
+23.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
20 Analysts

Profitability

Trailing P/E Ratio
39.03
Forward P/E Ratio
26.34
P/E Growth
2.77
Net Income
$3.90 billion
Pretax Margin
18.91%

Debt

Sales & Book Value

Annual Sales
$23.88 billion
Cash Flow
$11.12 per share
Price / Cash Flow
18.08
Book Value
$68.60 per share
Price / Book
2.93

Miscellaneous

Free Float
635,515,000
Market Cap
$143.85 billion
Optionable
Optionable
Beta
0.77

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NYSE:DHR) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners